Skip to content

Clinical trials

Phase 1 Respiratory Tract Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Phase: Phase 1 Country / region: China Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CanSino Biologics Inc.2
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1
Joincare Pharmaceutical Group Industry Co., Ltd1
Shenzhen Shenxin Biotechnology Co., Ltd1
Zhong Wang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections6
Bacterial Infections2
Pneumonia2
Respiratory Syncytial Virus Infections2
Respiratory Tract Diseases2
Intraabdominal Infections1
Urinary Tract Infections1
Virus Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.